The Biotech Growth Trust PLC
Research The Biotech Growth Trust PLC (BIOG) on Bullrun: market cap GBX 26.54B, P/E 2.5. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBIOG
- ExchangeLSE
- CountryUnited States
- SectorFinancial Services
- IndustryAsset Management
- CurrencyGBX
- Market capGBX 26.54B
- P/E2.5
- Financial periodFY2026
- RevenueGBP 133.86M
- Revenue growth269.9%
- Net incomeGBP 130.26M
- Free cash flow-GBP 4.84M
Valuation Snapshot
latest market cap is GBX 26.54B; P/E is 2.5.
Peer valuation comparison
Latest P/E is 2.54x versus a Financial Services sector median of 13.41x (81.1% below).
Latest P/E is 2.54x versus a United States median of 23.75x (89.3% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | GBP 133.86M | GBP 130.26M | -GBP 4.84M | n/a | 5.58 | GBP 0 | GBP 12.32M | GBP 281.92M |
| FY2025 | -GBP 78.81M | -GBP 82.66M | -GBP 5.09M | n/a | -2.62 | GBP 8.45M | n/a | GBP 221.21M |
| FY2024 | GBP 78.00M | GBP 74.60M | -GBP 4.24M | n/a | 2.07 | GBP 2.13M | GBP 47.08M | GBP 361.31M |
| FY2023 | -GBP 37.65M | -GBP 41.30M | -GBP 5.89M | n/a | -1.03 | GBP 2.77M | GBP 20.17M | GBP 330.29M |
| FY2022 | -GBP 209.71M | -GBP 202.42M | -GBP 12.14M | n/a | -4.89 | GBP 0 | GBP 31.74M | GBP 394.21M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | GBX 26.54B | 2.5 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 GBX.
About The Biotech Growth Trust PLC
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index.
Related stock research
Other Financial Services stocks
Frequently asked questions
What is The Biotech Growth Trust PLC's market cap?
The Biotech Growth Trust PLC's market capitalization is GBX 26.54B.
What is The Biotech Growth Trust PLC's P/E ratio?
The Biotech Growth Trust PLC's price-to-earnings (P/E) ratio is 2.5.
What does The Biotech Growth Trust PLC do?
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC.